NanoViricides, Inc. (NASDAQ:NNVC) | WebDisclosure

Basculer en Français

9480	Companies
185527	Keywords
117915	Articles
99372	Press releases

Home
Companies
NanoViricides, Inc.

BRIEF

published on 09/30/2025 at 14:50, 2 months 5 days ago

NanoViricides' NV-387 Advances in Clinical Trials

NanoViricides NV-387 Clinical Trials Antiviral Therapy Funding Challenges
PRESS RELEASE

published on 09/30/2025 at 14:45, 2 months 5 days ago

NanoViricides, Inc. Has Filed its Annual Report
NanoViricides reports progress on antiviral NV-387 in Phase II clinical trials with potential to revolutionize treatment for respiratory viral infections. Annual report highlights achievements and funding status

NanoViricides NV-387 Clinical Trials Respiratory Infections Antiviral
BRIEF

published on 09/11/2025 at 14:35, 2 months 24 days ago

NanoViricides to Present at LSX World Congress in Boston

NanoViricides NV-387 Clinical Trials Antiviral Drug LSX Congress
BRIEF

published on 09/11/2025 at 14:35, 2 months 24 days ago

NanoViricides sera présenté au congrès mondial LSX à Boston

NanoViricides NV-387 Essais Cliniques Médicament Antiviral Congrès LSX
PRESS RELEASE

published on 09/11/2025 at 14:30, 2 months 24 days ago

RETRANSMISSION: NanoViricides to Present at the Life Science Executive Partnering (LSX) Congress in Boston on September 17, 2025
NanoViricides, Inc. announces participation in LSX World Congress 2025 to present revolutionary broad-spectrum antiviral drug NV-387 and potential impact on viral infections

NanoViricides NV-387 Antiviral Drug Viral Infections LSX World Congress
BRIEF

published on 09/09/2025 at 14:35, 2 months 26 days ago

NanoViricides to Showcase Revolutionary Antiviral Drug at LSX Congress

NanoViricides NV-387 Antiviral Drugs Clinical Trial LSX Congress
BRIEF

published on 09/09/2025 at 14:35, 2 months 26 days ago

NanoViricides présentera un médicament antiviral révolutionnaire au congrès LSX

NanoViricides NV-387 Essai Clinique Médicaments Antiviraux Congrès LSX
PRESS RELEASE

published on 09/09/2025 at 14:30, 2 months 26 days ago

NanoViricides to Present at the Life Science Executive Partnering (LSX) Congress in Boston on September 17, 2025
NanoViricides, Inc. to showcase revolutionary antiviral drug NV-387 at LSX World Congress 2025 in Boston. Update on drug pipeline and platform technologies by Dr. Diwan

NanoViricides NV-387 Antiviral Drug LSX World Congress Dr. Diwan
BRIEF

published on 08/18/2025 at 14:35, 3 months 18 days ago

NanoViricides Reports Promising Antiviral Drug NV-387 in Clinical Trials

NV-387 Clinical Trials Antiviral Drug Inflammation Anti-cancer
BRIEF

published on 08/18/2025 at 14:35, 3 months 18 days ago

NanoViricides annonce l'essai clinique prometteur du médicament antiviral NV-387

NV-387 Essais Cliniques Inflammation Anti-cancer Médicament Antiviral

Accesswire

Published on 12/05/2025 at 18:45, 33 minutes ago

Four Global Markets, One Engine: SMX Just Redefined What a Supply Chain Can Prove
Published on 12/05/2025 at 18:20, 58 minutes ago

NuRAN Announces Intention to Complete Consolidation in Preparation to the Restructuring Transaction
Published on 12/05/2025 at 18:00, 1 hour 18 minutes ago

SMX: A New Supply Chain Reality in the World's Four Largest Markets
Published on 12/05/2025 at 17:15, 2 hours 3 minutes ago

TRX GOLD Attending the 3rd Annual DealFlow Discovery Conference
Published on 12/05/2025 at 17:00, 2 hours 18 minutes ago

Three Trillion-Dollar Frontiers, One Technology: How SMX Is Everywhere at Once

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 18:58, 20 minutes ago

EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:26, 51 minutes ago

POS-Transaction in Own Shares
Published on 12/05/2025 at 18:15, 1 hour 2 minutes ago

Completion of merger to form Helvetia Baloise Holding Ltd
Published on 12/05/2025 at 17:51, 1 hour 26 minutes ago

Issue of Equity
Published on 12/05/2025 at 17:46, 1 hour 32 minutes ago

Booster Precision Components Holding GmbH announces the successful completion of its Written Procedure to amend and waive certain terms under the terms and conditions of the Bonds

Les Echos

Published on 12/05/2025 at 17:18, 2 hours ago

La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Published on 12/05/2025 at 17:18, 2 hours ago

The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 4 hours 7 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 4 hours 7 minutes ago

Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 5 hours 19 minutes ago

RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE

View all LES ECHOS COMFI WIRE